Tokyo, Dec. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060191) titled 'A Real-World Analysis of Temporal Trends in the Use of Insomnia Medications Using an Insurer Claims Database' on Dec. 26.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Daiichi Sankyo Co., Ltd.
Condition:
Condition - Insomnia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Using a Japanese health insurance claims database, we analyzed prescribing patterns of insomnia medications among adults with insomnia in 2016 and 2021, focusing on patients with specific comorbidities.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Insomnia Medication-Prescribed Patient Cohort
Individuals aged 18 years or older in fiscal year 2016 or 2021 who had an insomnia-related ICD-10 diagnosis (G47.0 or F51.0) and received at least one prescription for insomnia medications classified as ORA (N05CJ), BZD (N05CD), Z-drug (N05CF), or MRA (N05CH).
Comorbidity Cohort
Among individuals aged 18 years or older in fiscal year 2016 or 2021 who had an insomnia-related ICD-10 diagnosis (G47.0 or F51.0) and received at least one prescription for insomnia medications classified as ORA (N05CJ), BZD (N05CD), Z-drug (N05CF), or MRA (N05CH), those with specific comorbidities (ICD-10) that showed an increased frequency or were prespecified by clinical experts as having high clinical relevance.
Key exclusion criteria - No exclusion criteria were specified.
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 10 Month 07 Day
Anticipated trial start date - 2025 Year 12 Month 26 Day
Last follow-up date - 2026 Year 02 Month 27 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068810
Disclaimer: Curated by HT Syndication.
